CLASS I ONGOING Device recall · Reported 12 Aug 2026 · FDA Enforcement Report

Infinion Cx Lead Kit recalled by Boston Scientific

Boston Scientific Neuromodulation is recalling Infinion Cx Lead Kit, distributed in New York. The recall was initiated on 17 Jun 2026 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesModel/UDI-DI: SC-2317-50/08714729861614, SC-2317-70/08714729861638. All unused products.
Quantity recalled1079

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2879-2026
FDA event ID
98974
Recalling firm
Boston Scientific Neuromodulation, Valencia, CA
Classification
Class I
Status
Ongoing
Recall initiated
17 Jun 2026
FDA classified
5 Aug 2026
Reported
12 Aug 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Device type
Spinal Implants

Timeline

17 Jun 2026Recall initiated by company
5 Aug 2026Classified by FDA+49 days
12 Aug 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention, including lead explant and replacement.

Product as listed by the FDA

INFINION CX LEAD KIT, 50CM, Model: SC-2317-50, Material: M365SC2317500; INFINION CX LEAD KIT, 70CM, Model: SC-2317-70, Material: M365SC2317700. part of the Boston Scientific Spinal Cord Stimulator (SCS) Systems.

Where it was distributed

US: NY. OUS: Canada, Portugal, Spain, France, Netherlands, Great Britain, Italy, Israel, Serbia, Greece, Germany, United Arab Emirates, Ireland, Hungary, Czech Republic, Brazil, Colombia, Argentina

New York

Questions about this recall

Why was it recalled?

Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention, including lead explant and replacement.

Which lots are affected?

Model/UDI-DI: SC-2317-50/08714729861614, SC-2317-70/08714729861638. All unused products.

Where was it sold?

US: NY. OUS: Canada, Portugal, Spain, France, Netherlands, Great Britain, Italy, Israel, Serbia, Greece, Germany, United Arab Emirates, Ireland, Hungary, Czech Republic, Brazil, Colombia, Argentina

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Boston Scientific Neuromodulation

All 24

Other Spinal Implants recalls

All 1,159